Lis Christopher G, Patel Kamal, Gupta Digant
Cancer Treatment Centers of America (CTCA), 500 Remington Road, Schaumburg, Illinois, 60173, United States of America.
PLoS One. 2015 Jul 31;10(7):e0134617. doi: 10.1371/journal.pone.0134617. eCollection 2015.
BACKGROUND/AIMS: Previously we reported that higher patient satisfaction (PS) with service quality is associated with favorable survival outcomes in a variety of cancers. However, we cautioned the readers that patients with greater satisfaction might be the ones with better self-rated health (SRH), a well-established prognosticator of cancer survival. In other words, SRH could potentially confound the PS and survival relationship. We investigated this hypothesis in non-small cell lung cancer (NSCLC).
778 NSCLC patients (327 males and 451 females; mean age 58.8 years) treated at 4 Cancer Treatment Centers of America hospitals between July 2011 and March 2013. PS was measured on a 7-point scale ranging from "completely dissatisfied" to "completely satisfied". SRH was measured on a 7-point scale ranging from "very poor" to "excellent". Both were dichotomized into 2 categories: top box response (7) versus all others (1-6). Patient survival was the primary end point. Cox regression was used to evaluate the association between PS and survival controlling for covariates.
74, 70, 232 and 391 patients had stage I, II, III and IV disease respectively. 631 (81.1%) patients were "completely satisfied". 184 (23.7%) patients had "excellent" SRH. There was a weak but significant correlation between overall PS and SRH (Kendall's tau b = 0.19; p<0.001). On univariate analysis, "completely satisfied" patients had a significantly lower risk of mortality (HR = 0.75; 95% CI: 0.57 to 0.99; p = 0.04). Similarly, patients with "excellent" SRH had a significantly lower risk of mortality (HR = 0.61; 95% CI: 0.46 to 0.81; p = 0.001). On multivariate analysis controlling for stage at diagnosis, treatment history and gender, SRH was found to be a significant predictor of survival (HR = 0.67; 95% CI: 0.50 to 0.89; p = 0.007) while PS was not (HR = 0.86; 95% CI: 0.64 to 1.2; p = 0.32). Among the individual PS items, the only significant independent predictor of survival was "teams communicating with each other concerning your medical condition and treatment" (HR = 0.59; 95% CI: 0.36 to 0.94; p = 0.03).
SRH appears to confound the PS-survival relationship in NSCLC. SRH should be used as a control/stratification variable in analyses involving PS as a predictor of clinical cancer outcomes.
背景/目的:此前我们报道,在多种癌症中,患者对服务质量的更高满意度(PS)与良好的生存结局相关。然而,我们提醒读者,满意度更高的患者可能是那些自我健康评价(SRH)更好的患者,而SRH是癌症生存的一个公认的预后指标。换句话说,SRH可能会混淆PS与生存之间的关系。我们在非小细胞肺癌(NSCLC)中研究了这一假设。
2011年7月至2013年3月期间,在美国癌症治疗中心的4家医院接受治疗的778例NSCLC患者(327例男性和451例女性;平均年龄58.8岁)。PS采用从“完全不满意”到“完全满意”的7分制进行测量。SRH采用从“非常差”到“优秀”的7分制进行测量。两者均被分为两类:最高评分(7分)与其他所有评分(1 - 6分)。患者生存是主要终点。采用Cox回归评估PS与生存之间的关联,并对协变量进行控制。
分别有74、70、232和391例患者患有I期、II期、III期和IV期疾病。631例(81.1%)患者“完全满意”。184例(23.7%)患者SRH“优秀”。总体PS与SRH之间存在微弱但显著的相关性(肯德尔tau b = 0.19;p < 0.001)。单因素分析显示,“完全满意”的患者死亡风险显著较低(HR = 0.75;95%CI:0.57至0.99;p = 0.04)。同样,SRH“优秀”的患者死亡风险显著较低(HR = 0.61;95%CI:0.46至0.81;p = 0.001)。在对诊断分期、治疗史和性别进行多因素分析时,发现SRH是生存的显著预测因素(HR = 0.67;95%CI:0.50至0.89;p = 0.007),而PS不是(HR = 0.86;95%CI:0.64至1.2;p = 0.32)。在各个PS项目中,生存的唯一显著独立预测因素是“团队就您的病情和治疗相互沟通”(HR = 0.59;95%CI:0.36至0.94;p = 0.03)。
在NSCLC中,SRH似乎混淆了PS与生存之间的关系。在将PS作为临床癌症结局预测因素的分析中,SRH应作为控制/分层变量使用。